Business● LowSep 30 · Sep 30, 2026, 10:59 AM
Vanda posts late-stage trial win for HETLIOZ in DSWPD, setting up another label expansion
GlobeAlert Desk · curated from Seeking Alpha Tech · global
Vanda has achieved a late-stage trial victory for its drug HETLIOZ in treating DSWPD, which positions the company for further label expansion. This indicates progress in pharmaceutical development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
More in Business
Business19m agoAustralian Grand Prix Corporation’s Travis Auld resigns as CEOSydney Morning Herald · AustraliaBusiness20m agoNew home prices fall in China for the forty-first consecutive monthInfobae · ArgentinaBusiness21m agoWith new forum, can Hong Kong become the deal-making hub linking Asia and Middle East?South China Morning PostBusiness21m agoAdherence to consortia grows, and experts say 'interest-free' modality can be expensiveFolha de S.Paulo · Brazil